Frontlight ResearchEarly access
CompletedNo phase
Genicular Artery Embolization as Pain Treatment of Knee Osteoarthritis
Key facts
- Who runs it
- Copenhagen University Hospital, Rigshospitalet
- Where
- Denmark1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 17 people enrolled
- Started
- 20 Sept 2022
- Ended
- 19 Dec 2023
- Type of study
- Interventional
- Treatments tested
- Transarterial geniculate artery embolization
- Record updated
- 20 December 2024
Who can take part
- Age
- 30 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 27 criteriaShow less
Who can take part
- Body Mass Index < 35 kg / m2
- X-ray verified mild to moderate KOA (Kellgren Lawrence grade 1-3 [24]), obtained maximum 6 months prior to inclusion
- Moderate to severe knee pain during walking (Visual Analog Scale (VAS) > 50 mm) - resistant to minimum 3 months physiotherapy
- Willing, able, and mentally competent to provide informed consent
Who cannot take part
- Prior ipsilateral open knee surgery
- Current/recent (within 4 weeks) use of oral corticosteroids
- Estimated glomerular filtration rate < 60 ml / min / 1.73 m2 (All participants: blood sample maximum 30 days prior to GAE. Participants > 60 years: another blood sample maximum 3 months prior to last MRI scan with contrast agents)
- Local infection in knee or groin areas
- Generalized pain syndrome (e.g. fibromyalgia) or nerve root compression syndromes
- Active malignancy
- Known history of allergy to contrast media
- Diabetes (I+II)
- Liver disease
- Only one kidney, former kidney surgery, reduced kidney function or failure (chronic or acute)
- Diseases affecting the bone metabolism (E.g. severe osteoporosis, Paget's disease, or hyperparathyroidism)
- INR > 1.4, Platelets ≤ 40 x 109 / l (All participants: blood sample maximum 30 days prior to GAE)
- Moderate to severe pain in ipsilateral lower limb joints; VAS > 2
- Intermittent claudication
- Rheumatoid arthritis or seronegative arthropathies
- Ipsilateral arthroscopy within 6 months
- Ipsilateral intra-articular knee injection within 6 months
- Pregnant or planned pregnancy during the study period
- Lactation
- Contra-indications for MRI (e.g. metallic foreign bodies, etc)
- Manifest hyperthyroidism
- Antithrombotic treatment except acetylsalicylic acid
- American Society of Anesthesiologists classification > 3
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of this study is to investigate the safety and efficacy of geniculate artery embolization (GAE) as pain treatment in patients with mild to moderate knee osteoarthritis.
The group in the trial
- Mild to moderate knee osteoarthritis (Kellgren Lawrence Score 1-3)Treatment being tested
Geniculate artery embolization will be performed in all eligible participants.
Treatment: Transarterial geniculate artery embolization
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Genicular Artery Embolization as Pain Treatment of Mild to Moderate Knee Osteoarthritis
- Record updated
- 20 December 2024